Xaira Therapeutics
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $553M
Investors
- 13
About Xaira Therapeutics
Based in California, US, and founded in 2023 by Joe (Joe Watchwell) Watson, Buwei Huang, Nathaniel Bennett, and Philip Leung, Xaira Therapeutics, Inc. operates as a biotechnology company that provides advances in AI to transform how we treat disease. In April 2024, Xaira Therapeutics, Inc. The company offers an AI platform designed to streamline the drug discovery process. Xaira's advanced generative AI is used for image generation to design molecular structures for drugs. The firm operates across three core areas: machine learning research to deepen biological insights, data generation to power advanced models, and therapeutic product development. The company focused on creating treatments that address a wide range of medical conditions, aiming to enhance patient outcomes and transform healthcare through technology-driven solutions.
Who invested in Xaira Therapeutics
13 investors across 2 rounds
See all investors in Xaira Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xaira Therapeutics
Who invested in Xaira Therapeutics?
Xaira Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xaira Therapeutics raised?
Xaira Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Xaira Therapeutics last raise money?
Xaira Therapeutics's most recent round on record is a Series A, in Apr 2024.
What does Xaira Therapeutics do?
Based in California, US, and founded in 2023 by Joe (Joe Watchwell) Watson, Buwei Huang, Nathaniel Bennett, and Philip Leung, Xaira Therapeutics, Inc.
Where is Xaira Therapeutics headquartered?
Xaira Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Xaira Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xaira Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xaira Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.